Avastin: Will FDA Rescind Approval of Breast Cancer Drug? | ThirdAge
Links shared publicly online about this topic.
- 866total visits
Avastin: Will FDA Rescind Approval of Breast Cancer Drug? | ThirdAge
View full resource at thirdage.com
Tags: Cancer, Cancer Medication, Breast Cancer, Breast Cancer Medication, Colorectal Cancer Medication, Women's Health, FDA, Avastin
Most Recently Shared on September 18, 2010 at 12:34 am By:
Avastin: Will FDA Rescind Approval of Breast Cancer Drug? http://bit.ly/99FTuF
Pushing the envelope : Nature Biotechnology : Nature Publishing Group
nature.com — “The US Food and Drug Administration (FDA) should follow its advisory panels and rescind metastatic breast cancer from Avastin's label.” View full resource at nature.com
Most Recently Shared on August 8, 2011 at 6:57 pm By:
More on Avastin breast cancer use in Nature Biotech: If FDA doesn't pull it, fast-track approval will lose credibility. http://bit.ly/nMFiAP
Cancer Treatment Drug News: FDA Pulls Breast Cancer Treatment Avastin | ThirdAge
thirdage.com — “Cancer treatment drug news broke today whenU.S. federal regulators said they were going to revoke approval of the widely-used drug Avastin for use in treating patients with breast cancer.The Food and Drug Administration announced plans to withdraw” View full resource at thirdage.com
Most Recently Shared on December 17, 2010 at 2:50 pm By:
Cancer Treatment Drug News: FDA Pulls Breast Cancer Treatment Avastin http://bit.ly/eQYEDY
Are Death Panels For Overpriced Cancer Drugs Coming To The FDA? - Robert Langreth - Treatments - Forbes
blogs.forbes.com — “The FDA faces a key decision this month on whether to rescind approval of Roche's expensive cancer drug Avastin for treating breast cancer. The drug slightly delays the time it takes tumors to grow on a scan, but has failed to show it can either improve symptoms or help women [...]” View full resource at blogs.forbes.com
Most Recently Shared on December 2, 2010 at 4:35 pm By:
Drugs and Devices OW OW Health
Are Death Panels For Overpriced Cancer Drugs Coming To The FDA?: The FDA faces a key decision this month o... http://bit.ly/eNKiv0 #drug
FDA considers revoking approval of Avastin for advanced breast cancer
washingtonpost.com — “Federal regulators are considering taking the highly unusual step of rescinding approval of a drug that patients with advanced breast cancer turn to as a last-ditch hope.” View full resource at washingtonpost.com
Most Recently Shared on August 16, 2010 at 1:37 pm By:
Kenny Lin, MD Family Medicine Doctor, Physician, and Doctor
FDA considers revoking approval of Avastin for advanced breast cancer: http://wapo.st/az2pZr
FDA considers revoking approval of Avastin for advanced breast cancer
washingtonpost.com — “Federal regulators are considering taking the highly unusual step of rescinding approval of a drug that patients with advanced breast cancer turn to as a last-ditch hope.” View full resource at washingtonpost.com
Most Recently Shared on August 16, 2010 at 10:15 am By:
Hisham Rana, MD Doctor and Physician
News: US FDA considers revoking approval of Avastin for advanced breast cancer http://bit.ly/aScGK8 - #health
FDA considers revoking approval of Avastin for advanced breast cancer
washingtonpost.com — “Federal regulators are considering taking the highly unusual step of rescinding approval of a drug that patients with advanced breast cancer turn to as a last-ditch hope.” View full resource at washingtonpost.com
Most Recently Shared on August 16, 2010 at 7:26 am By:
HealthTrendster Health Executive
FDA considers revoking approval of Avastin for advanced breast cancer http://ow.ly/18Az6K
FDA considers revoking approval of Avastin for advanced breast cancer
washingtonpost.com — “Federal regulators are considering taking the highly unusual step of rescinding approval of a drug that patients with advanced breast cancer turn to as a last-ditch hope.” View full resource at washingtonpost.com
Most Recently Shared on August 16, 2010 at 4:55 am By:
krupali tejura, m.d. Oncologist, Radiation Oncologist, Physician, and Doctor
Cancer drug Avastin is in debate over questions of medical spending vs effectiveness. - http://wpo.st/uLg0
FDA panel recommends rescinding Avastin | Top Industry News, Statistics, Research and Trends | BNET
industry.bnet.com — “A federal advisory panel is recommending that the Food and Drug Administration remove Genentech Inc.'s multibillion-dollar cancer drug Avastin as an approved treatment for a type of breast cancer. The recommendation from the panel of experts " if the FDA follows suit " could disgorge about $1 billion in breast cancer sales from Avastin, which records sales in excess of $6 billion a year. The FDA is expected to make its final decision by Sept. 17. Avastin costs about $40,000 for a course of treat” View full resource at industry.bnet.com
Most Recently Shared on July 21, 2010 at 4:22 am By:
FDA panel recommends rescinding Avastin for breast cancer http://tinyurl.com/25ao9fh (via @pulsepad)
Breast Cancer Drug Avastin Approval Withdrawn by FDA Panel | ThirdAge Articles
thirdage.com — “Did breast cancer drug Avastin really work? While initial studies of the Roche breast cancer drug Avastin drug were promising, an FDA advisory panel voted 12-1 to withdraw approval for the drug. After more testing, it was said on Friday that the drug” View full resource at thirdage.com
Most Recently Shared on July 21, 2010 at 12:45 am By:
Breast Cancer Drug Avastin Approval Withdrawn by FDA Panel http://bit.ly/bAdQmn
Advertisement
